paraquat has been researched along with herbimycin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowy-Borowski, H; Cohen, J; Harrison, K; Keshan, C; Lanthier, P; Leahy, S; Lopatin, D; Miller, H; Muthukumaran, K; Pandey, S; Sandhu, JK; Sikorska, M; Weinstock, S | 1 |
1 other study(ies) available for paraquat and herbimycin
| Article | Year |
|---|---|
Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Topics: Administration, Oral; Animals; Cell Survival; Feasibility Studies; Male; Neurons; Neuroprotective Agents; Paraquat; Parkinson Disease; Rats; Rats, Long-Evans; Rifabutin; Solubility; Substantia Nigra; Treatment Outcome; Ubiquinone; Vitamins; Water | 2014 |